2019亚洲日韩新视频_97精品在线观看_国产成人精品一区二区_91精品网站在线观看

MOLECULAR CANCER RESEARCH

MOLECULAR CANCER RESEARCH期刊基本信息

MOLECULAR CANCER RESEARCH
  • 簡稱:MOL CANCER RES
  • 大類:醫(yī)學(xué)
  • 小類:細(xì)胞生物學(xué)
  • ISSN:1541-7786
  • IF值:4.484
  • 周期:Monthly
  • 是否SCI:SCI/SCIE
  • 是否OA:No
  • 出版地:UNITED STATES
  • 年文章數(shù):161
  • 審稿速度:偏慢,4-8周
  • 平均錄用比例:較易
投稿咨詢

MOLECULAR CANCER RESEARCH中文簡介

分子癌癥研究發(fā)表文章描述了對該領(lǐng)域有廣泛興趣的新的基礎(chǔ)癌癥研究發(fā)現(xiàn)。研究必須具有證明意義,并且該雜志將分子和細(xì)胞水平的分析放在首位,揭示了與癌癥風(fēng)險、發(fā)展和/或進(jìn)展相關(guān)的途徑和過程的新的機(jī)械洞察。重點領(lǐng)域包括所有癌癥相關(guān)途徑(包括細(xì)胞周期調(diào)節(jié)、細(xì)胞死亡、染色質(zhì)調(diào)節(jié)、DNA損傷和修復(fù)、基因和RNA調(diào)節(jié)、基因組學(xué)、癌基因和腫瘤抑制因子以及信號轉(zhuǎn)導(dǎo)),以及描述支持癌癥表型的新分子機(jī)制和相互作用的研究。為了充分考慮,提交的初步研究必須提供對現(xiàn)有通路功能的重要新見解,或解決與癌癥相關(guān)的生物學(xué)問題相關(guān)的新假設(shè)。分子癌癥研究接受提交的初步研究,評論和評論文章類型以及給編輯的信件。有關(guān)提交給作者的文章類型的描述和長度要求,請參閱分子癌癥研究的文章類別。AACR期刊都使用類似的編輯過程。請注意,分子癌癥研究不考慮上訴。提交作者必須熟悉AACR期刊的編輯政策,包括關(guān)于作者身份、出版道德、材料和數(shù)據(jù)的可用性以及數(shù)據(jù)分析和報告的重要信息。對手稿進(jìn)行嚴(yán)格的審查,以獲得高標(biāo)準(zhǔn)的科學(xué)價值,只有那些報告小說、及時和廣泛重要研究成果的手稿才被接受出版。

MOLECULAR CANCER RESEARCH英文簡介

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; and signal transduction), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.Molecular Cancer Research accepts submissions of primary research, review and commentary article types as well as letters to the editor. For descriptions and length requirements of the article types available to submitting authors see the Categories of Articles for Molecular Cancer Research. The AACR Journals all use a similar Editorial Process. Please note that Molecular Cancer Research does not consider appeals.Submitting authors must be familiar with the Editorial Policies of the AACR Journals covering important information on authorship, publishing ethics, availability of materials and data and data analysis and reporting.Manuscripts are stringently reviewed for high standards of scientific merit, and only those that report results of novel, timely, and broadly-significant research are accepted for publication.

國際期刊推選 論文翻潤預(yù)審發(fā)表!

選擇豐富服務(wù)快速通過率高一鍵快速領(lǐng)取私人專屬發(fā)表方案!

* 請認(rèn)真填寫需求信息,學(xué)術(shù)顧問24小時內(nèi)與您取得聯(lián)系。

主站蜘蛛池模板: 彭阳县| 丹东市| 长兴县| 交城县| 华宁县| 彭泽县| 郯城县| 阿拉善左旗| 巴里| 永城市| 平和县| 江城| 焉耆| 格尔木市| 昌宁县| 阿勒泰市| 新野县| 平度市| 武平县| 青铜峡市| 平南县| 凤庆县| 广丰县| 海伦市| 环江| 道真| 焉耆| 读书| 南平市| 康定县| 阿拉善盟| 精河县| 黄石市| 湖州市| 山东省| 久治县| 白水县| 水富县| 洛川县| 海林市| 古浪县|